Health Canada, through its Special Access Programme (SAP), allows doctors to gain access to non-marketed drugs and medical devices that have not yet been approved for sale in Canada.
The Donor Semen Special Access Programme (DSSAP) provides authority for a processor, distributor or importer to release a specific quantity of donor semen to a physician for use in the performance of assisted conception in exceptional cases.
This section contains links to reports and publications related to special access to drugs & health products.